Spectranetics Gives Philips Adjacent Territory In Image-Guided Therapy

The plum in the middle of Philips' intense period of M&A this summer was the €1.9 billion purchase of Spectranetics, which, combined with Philips Volcano, should create a $1 billion+ devices business within the image-guided therapy group by 2020. IGT senior vice president and general manager Bert van Meurs explains the rationale behind the deal, and what's next for Philips.

Frans van Houten was taking a peek into the future two and a half years ago when Philips Healthcare brought Volcano Corp. into the fold. "An important milestone in our strategy to become the leading systems integrator in the fast-growing image-guided minimally invasive surgery market," is how the group CEO described the deal that was completed in February 2015.

More from Deal-Making

More from In Vivo

Top 12 Pharma Companies: Pfizer Tops The Leaderboard Again

 

The world’s biggest pharmaceutical companies mostly saw growth in 2024 but 2025 promises to be more of a mixed bag with headwinds including losses of exclusivity, Medicare Part D redesign and challenges in the Chinese market.

Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”

 

Farideh Bischoff, chief medical officer of Heranova Lifesciences, discusses the urgent need for better diagnostic options and the latest innovations transforming care for endometriosis patients.

HealthTech Innovation Versus Clinician And System Awareness

 
• By 

Bringing AI and digital healthtech innovation to patients works most efficiently via a three-way partnership in which clinicians and cloud services have equal weighting with a powerhouse innovator, Royal Philips told In Vivo during ECR 2025.